您的位置: 首页 > 农业专利 > 详情页

ПРИМЕНЕНИЕ КОМПОЗИЦИИ НА ОСНОВЕ ИСПОЛЬЗУЕМЫХ В КИТАЙСКОЙ МЕДИЦИНЫ ВЕЩЕСТВ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ В ЦЕЛЯХ ВТОРИЧНОЙ ПРОФИЛАКТИКИ ИНФАРКТА МИОКАРДА
专利权人:
ТАСЛИ ФАРМАСЬЮТИКАЛ ГРУПП КО.; ЛТД. (CN)
发明人:
ЧЗАН Боли (CN),ШАН Хунцай (CN),ЯО Чэнь (CN),ЛЮ Баоянь (CN),ВЭН Вэйлян (CN),ЧЖАО Юйся (CN),ДАЙ Гохуа (CN),ГАО Сюмэй (CN),ЖЭНЬ Мин (CN),ЧЗАН Цзюньхуа (CN),ЦАО Хунбо (CN),МАО Цзинюань (CN),ХУ Сюэцзюнь (C
申请号:
RU2013103160/15
公开号:
RU2013103160A
申请日:
2011.06.28
申请国别(地区):
RU
年份:
2014
代理人:
摘要:
1. Use of a composition based on used in Chinese medicine substances for the preparation of pharmaceuticals for the secondary prevention of myocardial infarction, characterized in that the composition based on used in Chinese medicine substances prepared from a composition comprising crude drug with the following contents in percent by weight: 2 . Use according to claim 1, characterized in that the secondary prevention of myocardial infarction is intended to decrease the frequency of occurrence of cardiovascular events in patients after acute myocardial miokarda.3. Use according to claim 2, wherein the cardiovascular events are one or more diseases including reinfarction, severe arrhythmia, heart failure, cardiogenic shock and revaskulyarizatsiyu.4. Use according to claim 1, characterized in that the secondary prevention of myocardial infarction is intended to decrease the frequency of occurrence of non-cardiovascular events in patients after acute myocardial miokarda.5. Use according to claim 4, characterized in that the non-cardiovascular events are one or more diseases including stroke, pulmonary embolism, and peripheral vascular breach opuhol.6. Use according to claim 1, characterized in that the secondary prevention of myocardial infarction is intended to decrease the frequency of occurrence of events smerti.7. Use according to claim 6, wherein the event is the death of one or more of the following: death from coronary heart disease, death from other cardiovascular diseases and death from non-cardiovascular zabolevaniy.8. Use according to claim 1, characterized in that the secondary prevention of myocardial1. Применение композиции на основе используемых в китайской медицине веществ для приготовления лекарственных средств в целях вторичной профилактики инфаркта миокарда, отличающееся тем, что композицию на основе используемых в китайской медицине веществ приготавливают из состава, содержащего лекарственное сырье со следующим содержанием в процентах по весу:Radix
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充